serum ifn-α autoantibodies and immune cell dysregulation are linked to covid-19 severity
Published 2 years ago • 95 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
59:16
covid-19 and the immune response with dr. donna farber
-
43:40
sars cov2 immunology
-
53:34
akiko iwasaki: "immunology: antibodies" (11/17/2020)
-
49:06
professor kari nadeau: covid-19: immunity in progress
-
39:20
covid conversations: paul klenerman on immunology
-
2:39
antibodies shown to provide lasting immunity against covid-19
-
46:35
dr chan phetsouphanh – immune dysfunction persists following mild-to-moderate sars-cov-2 infection
-
47:47
dr qian zhang – autoantibodies against type i ifns in patients with severe covid-19 pneumonia
-
16:26
covid-19 pandemic update 101: t cell immunity vs. antibodies & prior exposure to other coronaviruses
-
53:35
fsr overview: immunosuppressive treatments & covid-19 vaccines
-
1:01:15
donna farber - respiratory immunity and covid-19
-
22:10
immune determinants of covid-19 disease presentation and severity by p. brodin | openpediatrics
-
3:00:15
2022 international day of immunology - science, state and challenges of covid-19 vaccines
-
4:07
prellis biologics' anti-covid-19 antibodies via bioprinted human lymph nodes | covid response | sosv
-
59:15
one virus, few treatments, many vaccines: an overview of global covid-19 treatment and prevention.
-
37:38
the keys to covid: vaccines, treatments, and immunity
-
57:50
adrian hayday - seeking correlates of protection and correlates of pathology in covid-19 patients
-
22:42
new innovations in protein detection and gene expression analysis for sars-cov-2 research
-
1:25:54
first responders: sars-cov-2 & the immune system